Outlook Therapeutics, Inc. (Nasdaq: OTLK) announced that Chief Executive Officer Bob Jahr participated in a Virtual Investor CEO Connect segment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA